For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210609:nBw9yB8vva&default-theme=true
Form 8.3 - WILLIS TOWERS WATSON PLC
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 08 June 2021
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
1,867,181 1.45% 231,116 0.18%
(2) Derivatives (other than options):
72,359 0.06% 94,581 0.07%
(3) Options and agreements to
purchase/sell: 6,100 0.00% 6,100 0.00%
TOTAL:
1,945,640 1.51% 331,797 0.26%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 11 253.1281 USD
Purchase 18 254.1106 USD
Purchase 41 254.1400 USD
Purchase 44 254.1500 USD
Purchase 53 254.0077 USD
Purchase 96 253.7760 USD
Purchase 99 253.1100 USD
Purchase 100 253.3300 USD
Purchase 100 253.9900 USD
Purchase 171 254.1014 USD
Purchase 192 253.6628 USD
Purchase 342 253.3595 USD
Purchase 520 253.1646 USD
Purchase 543 253.8637 USD
Purchase 600 253.4899 USD
Purchase 749 253.0544 USD
Purchase 1,000 253.9045 USD
Purchase 1,043 254.5282 USD
Purchase 1,100 253.8272 USD
Purchase 1,159 253.7455 USD
Purchase 1,296 253.9477 USD
Purchase 1,500 254.3833 USD
Purchase 1,544 253.5435 USD
Purchase 1,802 253.7099 USD
Purchase 2,486 253.5518 USD
Purchase 2,529 253.5217 USD
Purchase 3,375 253.4864 USD
Purchase 3,616 253.3372 USD
Purchase 4,156 254.0515 USD
Purchase 5,373 254.1733 USD
Purchase 10,810 254.5700 USD
Purchase 12,423 253.9115 USD
Purchase 13,796 254.5928 USD
Purchase 26,166 253.7006 USD
Purchase 33,457 253.4957 USD
Sale 1 254.4600 USD
Sale 4 254.3675 USD
Sale 5 254.0100 USD
Sale 7 254.0371 USD
Sale 28 253.9850 USD
Sale 64 253.7760 USD
Sale 141 253.0076 USD
Sale 467 253.6607 USD
Sale 765 253.3977 USD
Sale 1,043 254.5282 USD
Sale 1,400 254.4207 USD
Sale 1,721 253.6203 USD
Sale 2,446 253.5628 USD
Sale 4,624 253.5133 USD
Sale 4,928 253.3503 USD
Sale 5,006 254.2148 USD
Sale 9,594 254.5700 USD
Sale 13,796 254.5928 USD
Sale 35,043 253.4847 USD
Sale 50,000 253.7996 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 9 Jun 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or
Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -100 220.0000 American Jul 16, 2021
Call Options Purchased 100 240.0000 American Jul 16, 2021
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021
Notes
1. Where there are open option positions or open derivative positions (except
for CFDs), full details should be given. Full details of any existing
agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210609005474/en/
(https://www.businesswire.com/news/home/20210609005474/en/)
BARCLAYS PLC
Copyright Business Wire 2021